[artículo] 
inJournal of Clinical Psychopharmacology > Año 2009 - Vol. 29 - No. 6 (Diciembre) . - pp. 537-541

Título :	Impact of cyp2d6 genotype on steady state serum concentrations of risperidone and 9 hydroxyrisperidone in patients using long acting injectable risperidone
Tipo de documento:	texto impreso
Autores:	Magnhild Hendset, Autor ; Espen Molden, Autor ; Helge Refsum, Autor
Fecha de publicación:	2022
Artículo en la página:	pp. 537-541
Idioma :	Inglés (eng) Idioma original : Inglés (eng)
Palabras clave:	Risperidona, 9-hidroxirisperidona, CYP2D6, Concentración sérica, Tabletas, Inyección de acción prolongada
Resumen:	An increased risk of adverse effects and discontinuation of risperidone therapy is observed in patients with impaired cytochrome P450 2D6 (CYP2D6) function on oral risperidone therapy. The present study is the first to investigate the impact of CYP2D6 genotype on serum concentrations of risperidone and 9-hydroxyrisperidone in patients using injectable long-acting risperidone.
Link:	./index.php?lvl=notice_display&id=29476

[artículo] Impact of cyp2d6 genotype on steady state serum concentrations of risperidone and 9 hydroxyrisperidone in patients using long acting injectable risperidone [texto impreso] / Magnhild Hendset, Autor ; Espen Molden, Autor ; Helge Refsum, Autor . - 2022 . - pp. 537-541.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2009 - Vol. 29 - No. 6 (Diciembre) . - pp. 537-541

Palabras clave:	Risperidona, 9-hidroxirisperidona, CYP2D6, Concentración sérica, Tabletas, Inyección de acción prolongada
Resumen:	An increased risk of adverse effects and discontinuation of risperidone therapy is observed in patients with impaired cytochrome P450 2D6 (CYP2D6) function on oral risperidone therapy. The present study is the first to investigate the impact of CYP2D6 genotype on serum concentrations of risperidone and 9-hydroxyrisperidone in patients using injectable long-acting risperidone.
Link:	./index.php?lvl=notice_display&id=29476